• Home
  • Company
    • Mission
    • Management Team
    • Locations
    • Investors
    • Awards
  • Products
    • Product Overview
    • Bafasal®
    • Bafador®
    • Product Pipeline
  • Strategy
    • Strategic Goals
  • Partnering
    • Co-Development
    • Become a Distributor
    • Grants
  • Sustainability
    • Sustainability Overview
    • Reports
  • Media
    • Events & Presentations
    • News
  • COVID-19
  • Contact
ch4natacbe9d58sbjk56
August 21, 2019

Proteon receives European grant to fight bacterial infections in fish farming, otherwise known as aquaculture farming.

Maria Rojek-Lucas Company News

A Łódź pharmaceutical company has received over 2 million Euros to reduce animal antibiotics in the human food chain.

In an attempt to find a solution to the well-known overuse of antibiotics in animals farmed for human consumption, the use of which has led to an increase in antibiotic resistant bacteria strains, Proteon Pharma has begun developing environmentally-friendly micro-organisms known as phages – a virus that infects and replicates within bacteria.

According to the American ‘Center For Disease Dynamics, Economics and Policy’  73 percent of the world\’s antibiotics are used in farming.

Proteon Phrama
Proteon Phrama has been given a 2.9 million EUR grant to help develop phages to fight bacterial infections in fish farming, otherwise known as aquaculture farming.

In October 2018 the EU voted to ban prophylactic use of antibiotics in farming, which will come into force in 2022.

While this will help fight antibiotic resistance it doesn’t help with the amount of diseases transmitted from animals to humans.

The World Health Organization says that as much as 60 percent of the pathogens that cause diseases in humans are of animal origin.

Matthew Tebeau from Proteon Pharmaceuticals said: “Products based on bacteriophages are an effective tool for fighting bacterial diseases in farmed fish, as they eliminate only the specific pathogenic bacteria while not damaging the animal’s microbiome.”
Matthew Tebeau from Proteon Pharmaceuticals said: “Products based on bacteriophages are an effective tool for fighting bacterial diseases in farmed fish, as they eliminate only the specific pathogenic bacteria while not damaging the animal’s microbiome.”

Specialising in farming, Proteon Phrama has now been given a 2.9 million EUR grant to help develop phages to fight bacterial infections in fish farming, otherwise known as aquaculture farming.

Matthew Tebeau, Member of the Management Board and Chief Operating Officer at Proteon Pharmaceuticals said in a press release: “Farmed fish producers are looking for efficient alternatives to antibiotic use and for effective preventive and curative treatments in aquaculture.

Matthew Tebeau from Proteon Pharmaceuticals said: “Products based on bacteriophages are an effective tool for fighting bacterial diseases in farmed fish, as they eliminate only the specific pathogenic bacteria while not damaging the animal’s microbiome.”
Matthew Tebeau from Proteon Pharmaceuticals said: “Products based on bacteriophages are an effective tool for fighting bacterial diseases in farmed fish, as they eliminate only the specific pathogenic bacteria while not damaging the animal’s microbiome.”

“Products based on bacteriophages are an effective tool for fighting bacterial diseases in farmed fish, as they eliminate only the specific pathogenic bacteria while not damaging the animal’s microbiome.”

The additional funding will allow now Proteon to improve and automate the process of searching for and selecting proper phages for use in aquaculture farming.

Proteon Joins The U.S. Poultry & Egg Association Proteon Pharmaceuticals włącza się w walkę z koronawirusem

Related Posts

aqua_shrimps

Company News

Proteon Pharmaceuticals and Skretting to co-develop new phage-based solutions for aquaculture

shutterstock_67011926q2

Company News

Proteon Pharmaceuticals – strategiczne partnerstwo handlowe z DuPont Animal Nutrition

shutterstock_67011926q2

Company News

Proteon Pharmaceuticals announces a strategic partnership in distribution with DuPont Animal Nutrition

Categories

  • Company News (17)
  • Proteon General News (1)

Recent Posts

  • Proteon Pharmaceuticals and Skretting to co-develop new phage-based solutions for aquaculture
  • Proteon Pharmaceuticals – strategiczne partnerstwo handlowe z DuPont Animal Nutrition
  • Proteon Pharmaceuticals announces a strategic partnership in distribution with DuPont Animal Nutrition
  • Addressing the Superbug Concern: Phage Therapy Could Beat Drug Resistant Illnesses
  • Proteon Pharmaceuticals Joins Research Efforts to Fight Coronavirus

Our Solutions

170131_salmonellafree_logo_456x181-e1486970860523

Contact Proteon

Follow Us —

Company

  • Mission
  • Management Team
  • Locations
  • Investors
  • Awards

Products

  • Product Overview
  • Bafasal®
  • Bafador®
  • Product Pipeline

Partnering

  • Co-Development
  • Become a Distributor
  • Grants

Strategy

  • Strategic Goals

Sustainability

  • Overview
  • Reports

Media

  • Events & Presentations
  • Media About Us
  • News
logo_proteon-white

CUSTOMER SERVICE:    +48 502-678-674     |     proteon@proteonpharma.com

Privacy Policy | Polityka Prywatności

Copyright © 2019 Proteon Pharmaceuticals, All Rights Reserved